Heteroleptic Iridium Complexes for OLED Efficiency and Lifespan
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current organic light-emitting devices (OLEDs) face limitations in achieving optimal luminescence efficiency and lifespan, despite advancements in viewing angles, response time, and luminance.
Innovation Solution
A composition comprising heteroleptic iridium complexes, specifically compounds represented by Formulas 1 and 2, is used in the organic layer of OLEDs to enhance luminescence efficiency and lifespan, where each compound includes iridium (Ir) with specific ligand configurations and bonding types, ensuring electrical neutrality and optimal light emission properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Illumination intensity
If conventional organic light-emitting devices are used, then viewing angles, response time, and luminance are improved, but luminescence efficiency and lifespan remain limited
Solution Approach 1:
The patent applies parameter changes by modifying the chemical composition and molecular structure of the emission layer. Specifically, it uses heteroleptic iridium complexes with particular ligand combinations (combining cyclometalating ligands with N^C-type ligands) to optimize photophysical properties, achieving both high luminance and extended device lifespan through controlled chemical parameter variations
Solution Approach 2:
The patent employs composite materials by creating a multi-component emission layer system. It combines iridium complexes with specific host materials and co-host materials, where each component contributes different functional properties. The heteroleptic iridium complex serves as a dopant within a composite organic matrix, enabling simultaneous optimization of luminescence efficiency and device stability
2Illumination intensity
If conventional organic light-emitting devices are used, then viewing angles, response time, and luminance are improved, but luminescence efficiency remains limited
Solution Approach 1:
The patent optimizes luminescence efficiency through parameter changes in the emitter molecular structure. By selecting specific heteroleptic iridium complexes with optimized ligand fields and coordinating environments, the patent achieves enhanced quantum efficiency and radiative decay rates, converting more electrical energy into light output
Solution Approach 2:
The patent utilizes the heavy atom effect of iridium to accelerate non-radiative relaxation pathways and achieve rapid exciton recombination. The strong spin-orbit coupling in iridium complexes enables fast intersystem crossing and phosphorescence emission, allowing the system to quickly convert electrical excitation into light output before energy loss occurs
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of these heteroleptic iridium complexes in the OLEDs' organic layer significantly improves luminescence efficiency and extends the lifespan of the devices, leading to enhanced performance in light emission and stability.
Implementation Method 1
The holes and the electrons recombine in the emission layer to produce excitons. These excitons transition from an excited state to a ground state to thereby generate light.
Implementation Method 2
A composition comprising heteroleptic iridium complexes, specifically compounds represented by Formulas 1 and 2, is used in the organic layer of OLEDs to enhance luminescence efficiency and lifespan
Data Source
AI summary
A composition, including a first compound represented by Formula 1 and a second compound represented by Formula 2: Formula 1 Ir(L11)n11(L12)n12(L13)n13 Formula 2 Ir(L21)n21(L22)n22(L23)n23 wherein L11, L12, L13, L21, L22, and L23 are each i) a bidentate ligand bonded to Ir of Formula 1 or 2 via two nitrogen atoms, ii) a bidentate ligand bonded to Ir of Formula 1 or 2 via a nitrogen atom and a carbon atom, or iii) a bidentate ligand bonded to Ir of Formula 1 or 2 via two carbon atoms, L11, L12, and L13 are different from one another; n11, n12, n21, and n22 are each independently 1 or 2; n13 and n23 are each independently 0 or 1; a sum of n11, n12, and n13 is 3; a sum of n21, n22, and n23 is 3; and L11 and L21 are different from each other.